Bill Text: NJ A3197 | 2024-2025 | Regular Session | Introduced
Bill Title: Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research from $1 million to $4 million; establishes dedicated, non-lapsing Cancer Research Fund.
Spectrum: Partisan Bill (Republican 2-0)
Status: (Introduced) 2024-01-09 - Introduced, Referred to Assembly Health Committee [A3197 Detail]
Download: New_Jersey-2024-A3197-Introduced.html
STATE OF NEW JERSEY
221st LEGISLATURE
PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION
Sponsored by:
Assemblywoman AURA K. DUNN
District 25 (Morris and Passaic)
Co-Sponsored by:
Assemblywoman N.Munoz
SYNOPSIS
Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research from $1 million to $4 million; establishes dedicated, non-lapsing Cancer Research Fund.
CURRENT VERSION OF TEXT
Introduced Pending Technical Review by Legislative Counsel.
An Act concerning the New Jersey State Commission on Cancer Research, amending P.L.1982, c.40, supplementing P.L.1983, c.6, and repealing section 8 of P.L.1983, c.6.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. Section 5 of P.L.1982, c.40 (C.54:40A-37.1) is amended as follows:
5. The sum of [$1,000,000.00] $4,000,000 of the tax collected pursuant to section 301 of P.L.1948, c.65 (C.54:40A-8), shall be annually deposited by the State Treasurer in [a special account to be known as] the Cancer Research Fund, [except that for Fiscal Year 1983 only $500,000.00 shall be deposited in that account] a nonlapsing, revolving fund established pursuant to section 3 of P.L. , c... (C. ) (pending before the Legislature as this bill). Moneys in the Cancer Research Fund shall be [annually appropriated toward the funding of] utilized by the New Jersey State Commission on Cancer Research, established pursuant to P.L.1983, c.6 (C.52:9U-1 et seq.), [or to] for cancer research projects authorized and approved by the commission, as well as any other commission responsibilities authorized under State law.
(cf: P.L.1982, c.40, s.5)
2. Section 8 of P.L.1983, c.6 (C.52:9U-8) is repealed.
3. (New Section) a. There is established in the Department of the Treasury a nonlapsing, revolving fund to be known as the Cancer Research Fund. This fund shall be the repository for monies provided pursuant to section 5 of P.L.1982, c.40 (C.54:40A-37.1) and any other funds approved by the Department of Health or the commission. Moneys deposited in the fund, and any interest earned thereon, shall be used exclusively for the purpose of providing grants for cancer research projects authorized and approved by the commission, as well as any other commission responsibilities authorized under State law.
b. The State Treasurer shall be the custodian of the fund and all disbursements from the fund shall be made by the State Treasurer upon vouchers signed by the chairperson of the commission or the chairperson's designee. The monies in the fund shall be invested and reinvested by the Director of the Division of Investment in the Department of the Treasury in the same manner as other trust funds in the custody of the State Treasurer, in the manner provided by law. Interest received on the monies in the fund shall be credited to the fund.
4. This act shall take effect immediately.
STATEMENT
This bill increases the amount of cigarette and other tobacco products tax revenues provided to the New Jersey Commission on Cancer Research (NJCCR) from $1 million to $4 million. The bill also establishes a dedicated, non-lapsing Cancer Research Fund within the Department of the Treasury. In doing so, the bill prioritizes funding for cancer research in an equivalent manner as State funding for spinal cord and brain injury research. Dedicated State funding for these two causes generally ranges from approximately $4 million to $6 million annually. The NJCCR promotes significant and original research in New Jersey into the causes, prevention, treatment and palliation of cancer and serves as a resource to providers and consumers of cancer care and treatment services.
Currently, under statute, the NJCCR annually receives $1.0 million of cigarette and other tobacco products tax revenues. This money is deposited into an existing lapsing Cancer Research Fund and then appropriated to the commission. In recent years, pursuant to the annual appropriations act, this money has been transferred from the Cancer Research Fund to the General Fund. The appropriations act then provides the NJCCR funding via a budget line. Despite the statutory requirement, in FY 2020 and FY 2021, the NJCCR was appropriated $2.0 million in funding.
Under the bill, the existing Cancer Research Fund is replaced by a non-lapsing, revolving fund. This fund is to be the repository of the $4.0 million of cigarette and other tobacco products tax revenues deposited into the account under the bill and any other funds approved by the Department of Health or the commission. Moneys deposited in the fund, and any interest earned thereon, are to be used exclusively for the purpose of providing grants for cancer research projects authorized and approved by the commission, as well as any other commission responsibilities authorized under State law.
The State Treasurer is the custodian of the fund and all disbursements from the fund are to be made by the State Treasurer upon vouchers signed by the chairperson of the commission or the chairperson's designee. The monies in the fund are to be invested and reinvested by the Director of the Division of Investment in the Department of the Treasury in the same manner as other trust funds in the custody of the State Treasurer, in the manner provided by law. Interest received on the monies in the fund are to be credited to the fund.
